All In Biotech

Free tool

FAERS Monitor: Skyclarys

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216718 or its brand name (Skyclarys, Omaveloxolone). Reports on generic versions are filed under their own applications.

Reports

1,818

Serious

762

42% of reports

Hospitalization

451

Death reported

94

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue162
  • nausea134
  • hepatic enzyme increased130
  • product dose omission issue107
  • headache105
  • diarrhoea95
  • blood cholesterol increased86
  • muscle spasms78
  • fall76
  • atrial fibrillation69
  • alanine aminotransferase increased68
  • death63
  • urinary tract infection62
  • abdominal pain upper60
  • friedreich^s ataxia59

Reports by year received

View as table
YearReports
2023171
2024665
2025568
2026414

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,341 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
hepatic enzyme increasedSignal13022.118.72,601
blood cholesterol increasedSignal8621.417.41,651
alanine aminotransferase increasedSignal6812.810.2731
atrial fibrillationSignal698.26.5431
muscle spasmsSignal784.94.0242
product dose omission issueSignal1074.23.5262
urinary tract infectionSignal624.23.3149
abdominal pain upperSignal603.42.699
fallSignal762.62.177
fatigueSignal1622.42.1137
nausea1342.01.764
headache1051.91.648
diarrhoea951.71.428
death630.80.72
friedreich^s ataxia590.00.0671,687

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.